APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025188 pages

Choose your research edition.

Industry ResearchDipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Dipeptidyl Peptidase-4 (DPP-4) Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors include Boehringer, Bristol-Myers Squibb, AstraZeneca, Glaxo Smith Kline, Pfizer, Eli Lilly, Novo Nordisk and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dipeptidyl Peptidase-4 (DPP-4) Inhibitors sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market size, projected growth trends, production technologies, key applications, and end-use industries.

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Company

Boehringer

Bristol-Myers Squibb

AstraZeneca

Glaxo Smith Kline

Pfizer

Eli Lilly

Novo Nordisk

Sanofi

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Type

Sitagliptin

Vildagliptin

Saxagliptin

Linagliptin

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Application

Hospital

Clinic

Others

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Trends Table 2. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Drivers Table 3. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Opportunities and Challenges Table 4. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Restraints Table 5. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Manufacturers Table 9. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturers, Product Type & Application Table 13. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Sitagliptin Table 17. Major Manufacturers of Vildagliptin Table 18. Major Manufacturers of Saxagliptin Table 19. Major Manufacturers of Linagliptin Table 20. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2021-2026) & (K Units) Table 22. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2027-2032) & (K Units) Table 23. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2021-2026) Table 24. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2027-2032) Table 25. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2021-2026) & (K Units) Table 27. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2027-2032) & (K Units) Table 28. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type (2021-2026) Table 29. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Others Table 33. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2021-2026) & (K Units) Table 35. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2027-2032) & (K Units) Table 36. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2021-2026) Table 37. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2027-2032) Table 38. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2021-2026) & (K Units) Table 40. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2027-2032) & (K Units) Table 41. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application (2021-2026) Table 42. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application (2027-2032) Table 43. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2021-2026) & (K Units) Table 45. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2021-2026) Table 46. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021-2026) & (K Units) Table 50. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2027-2032) & (K Units) Table 51. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021-2026) & (K Units) Table 53. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2027-2032) & (K Units) Table 60. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2021-2026) Table 64. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2027-2032) Table 65. Boehringer Company Information Table 66. Boehringer Business Overview Table 67. Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 69. Boehringer Recent Development Table 70. Bristol-Myers Squibb Company Information Table 71. Bristol-Myers Squibb Business Overview Table 72. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 74. Bristol-Myers Squibb Recent Development Table 75. AstraZeneca Company Information Table 76. AstraZeneca Business Overview Table 77. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 79. AstraZeneca Recent Development Table 80. Glaxo Smith Kline Company Information Table 81. Glaxo Smith Kline Business Overview Table 82. Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 84. Glaxo Smith Kline Recent Development Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 89. Pfizer Recent Development Table 90. Eli Lilly Company Information Table 91. Eli Lilly Business Overview Table 92. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 94. Eli Lilly Recent Development Table 95. Novo Nordisk Company Information Table 96. Novo Nordisk Business Overview Table 97. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 99. Novo Nordisk Recent Development Table 100. Sanofi Company Information Table 101. Sanofi Business Overview Table 102. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio Table 104. Sanofi Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Distributors List Table 108. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Image Figure 2. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size (2021-2032) & (US$ Million) Figure 4. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (2021-2032) & (K Units) Figure 5. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Sitagliptin Image Figure 9. Vildagliptin Image Figure 10. Saxagliptin Image Figure 11. Linagliptin Image Figure 12. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2021-2032) Figure 15. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Others Image Figure 21. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2021-2032) Figure 24. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application (2021-2032) Figure 27. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2021-2032) Figure 29. U.S. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2021-2032) Figure 34. Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2021-2032) Figure 41. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2021-2032) Figure 49. Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Figure 60. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Figure 62. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Sitagliptin
  • Vildagliptin
  • Saxagliptin
  • Linagliptin
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Boehringer
  • Bristol-Myers Squibb
  • AstraZeneca
  • Glaxo Smith Kline
  • Pfizer
  • Eli Lilly
  • Novo Nordisk
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Dynamics
  1. 2.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Trends
  2. 2.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Drivers
  3. 2.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Opportunities and Challenges
  4. 2.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Restraints
3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market by Manufacturers
  1. 3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Manufacturers (2021-2026)
  3. 3.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturers, Product Type & Application
  7. 3.7 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Tier 1, Tier 2, and Tier 3
4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market by Type
  1. 4.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Type Introduction
  2. 4.1.1 Sitagliptin
  3. 4.1.2 Vildagliptin
  4. 4.1.3 Saxagliptin
  5. 4.1.4 Linagliptin
  6. 4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type
  7. 4.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2021-2032)
  9. 4.2.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2021-2032)
  10. 4.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type
  11. 4.3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2021-2032)
  13. 4.3.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type (2021-2032)
5 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market by Application
  1. 5.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application
  6. 5.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2021-2032)
  8. 5.2.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2021-2032)
  9. 5.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application
  10. 5.3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2021-2032)
  12. 5.3.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application (2021-2032)
6 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region
  1. 6.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2021-2032)
  3. 6.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2021-2026)
  4. 6.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region
  1. 7.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region
  2. 7.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2021-2026)
  4. 7.1.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2027-2032)
  5. 7.1.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032)
  8. 7.2.2 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032)
  11. 7.3.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer
  2. 8.1.1 Boehringer Company Information
  3. 8.1.2 Boehringer Business Overview
  4. 8.1.3 Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  6. 8.1.5 Boehringer Recent Developments
  7. 8.2 Bristol-Myers Squibb
  8. 8.2.1 Bristol-Myers Squibb Company Information
  9. 8.2.2 Bristol-Myers Squibb Business Overview
  10. 8.2.3 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  12. 8.2.5 Bristol-Myers Squibb Recent Developments
  13. 8.3 AstraZeneca
  14. 8.3.1 AstraZeneca Company Information
  15. 8.3.2 AstraZeneca Business Overview
  16. 8.3.3 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  18. 8.3.5 AstraZeneca Recent Developments
  19. 8.4 Glaxo Smith Kline
  20. 8.4.1 Glaxo Smith Kline Company Information
  21. 8.4.2 Glaxo Smith Kline Business Overview
  22. 8.4.3 Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  24. 8.4.5 Glaxo Smith Kline Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Eli Lilly
  32. 8.6.1 Eli Lilly Company Information
  33. 8.6.2 Eli Lilly Business Overview
  34. 8.6.3 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  36. 8.6.5 Eli Lilly Recent Developments
  37. 8.7 Novo Nordisk
  38. 8.7.1 Novo Nordisk Company Information
  39. 8.7.2 Novo Nordisk Business Overview
  40. 8.7.3 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  42. 8.7.5 Novo Nordisk Recent Developments
  43. 8.8 Sanofi
  44. 8.8.1 Sanofi Company Information
  45. 8.8.2 Sanofi Business Overview
  46. 8.8.3 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
  48. 8.8.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Value Chain Analysis
  2. 9.1.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Mode & Process
  6. 9.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Distributors
  9. 9.2.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst